Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001140361-22-010241
Filing Date
2022-03-18
Accepted
2022-03-18 17:24:27
Documents
9
Period of Report
2022-03-18

Document Format Files

Seq Description Document Type Size
1 PREM14A ny20003153x3_prem14a.htm PREM14A 5309621
2 FILING FEES TABLE ny20003153x3_ex107.htm EX-FILING FEES 32650
3 logo_centerviewpartnersv2.jpg GRAPHIC 20936
4 logo_neogen.jpg GRAPHIC 30841
5 ny20003153x3_flowchart0x1.jpg GRAPHIC 70366
6 ny20003153x3_flowchart0x2.jpg GRAPHIC 108364
7 ny20003153x3_flowchart0x3.jpg GRAPHIC 111789
8 ny20003153x3_piechart01.jpg GRAPHIC 64155
9 ny20003153x3_piechart02.jpg GRAPHIC 47573
  Complete submission text file 0001140361-22-010241.txt   5967411
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: PREM14A | Act: 34 | File No.: 000-17988 | Film No.: 22753529
SIC: 2835 In Vitro & In Vivo Diagnostic Substances